Effectiveness of Mobile-health Self Management on Quality of Life of Patients Undergoing Chemotherapy
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 50
- Primary Endpoint
- Patient's Self-efficacy
Study Overview
Brief Summary
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Detailed Description
The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •adult patients diagnosed with cancer
- •patients who use smart phone
Exclusion Criteria
- •patients with cancer with comorbidity
Arms & Interventions
Mobile health self-management
Intervention: Mobile-health self management (Behavioral)
Outcomes
Primary Outcomes
Patient's Self-efficacy
Time Frame: four weeks
The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.
Patient's Quality of life
Time Frame: Four weeks
The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.
Secondary Outcomes
No secondary outcomes reported
Investigators
Erna Rochmawati
Associate Professor
Universitas Muhammadiyah Yogyakarta